BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanda T, Sasaki R, Nakamoto S, Haga Y, Nakamura M, Shirasawa H, Okamoto H, Yokosuka O. The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity. Biochem Biophys Res Commun. 2015;466:567-571. [PMID: 26388050 DOI: 10.1016/j.bbrc.2015.09.083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Xiang Z, Li J, Lu D, Wei X, Xu X. Advances in multi-omics research on viral hepatitis. Front Microbiol 2022;13:987324. [DOI: 10.3389/fmicb.2022.987324] [Reference Citation Analysis]
2 Kanda T, Sasaki R, Masuzaki R, Moriyama M. Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites. Artif Intell Gastroenterol 2021; 2(1): 1-9 [DOI: 10.35712/aig.v2.i1.1] [Reference Citation Analysis]
3 Alqarni MH, Foudah AI, Muharram MM, Labrou NE. The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections. Cells 2021;10:460. [PMID: 33669990 DOI: 10.3390/cells10020460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
4 Kanda T, Sasaki R, Masuzaki R, Takahashi H, Mizutani T, Matsumoto N, Nirei K, Moriyama M. Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease. Int J Mol Sci 2020;21:E6384. [PMID: 32887515 DOI: 10.3390/ijms21176384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kanda T, Sasaki R, Masuzaki R, Matsumoto N, Ogawa M, Moriyama M. Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection. Viruses 2020;12:E533. [PMID: 32408660 DOI: 10.3390/v12050533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
6 Hackett BA, Dittmar M, Segrist E, Pittenger N, To J, Griesman T, Gordesky-Gold B, Schultz DC, Cherry S. Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses. mBio 2019;10:e01446-19. [PMID: 31289184 DOI: 10.1128/mBio.01446-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Ogawa M, Kanda T, Suganami A, Nakamoto S, Win NN, Tamura Y, Nakamura M, Matsuoka S, Yokosuka O, Kato N, Ohara O, Okamoto H, Moriyama M, Shirasawa H. Antiviral activity of zinc sulfate against hepatitis A virus replication. Future Virology 2019;14:399-406. [DOI: 10.2217/fvl-2019-0031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Xu L, Wang L, Zhou L, Dorfman RG, Pan Y, Tang D, Wang Y, Yin Y, Jiang C, Zou X, Wu J, Zhang M. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming. Neoplasia 2019;21:429-41. [PMID: 30933885 DOI: 10.1016/j.neo.2019.03.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
9 Su P, Shih C. Emerging New Therapies for Viral Hepatitis. Viral Hepatitis in Children 2019. [DOI: 10.1007/978-981-13-0050-9_16] [Reference Citation Analysis]
10 Nguyen YH, Lampkin BJ, Venkatesh A, Ellern A, Rossini AJ, VanVeller B. Open-Resonance-Assisted Hydrogen Bonds and Competing Quasiaromaticity. J Org Chem 2018;83:9850-7. [PMID: 30024169 DOI: 10.1021/acs.joc.8b01331] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Win NN, Kanda T, Nakamoto S, Moriyama M, Jiang X, Suganami A, Tamura Y, Okamoto H, Shirasawa H. Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression. Int J Med Sci 2018;15:1153-9. [PMID: 30123052 DOI: 10.7150/ijms.27489] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li Y, Zhang M, Dorfman RG, Pan Y, Tang D, Xu L, Zhao Z, Zhou Q, Zhou L, Wang Y, Yin Y, Shen S, Kong B, Friess H, Zhao S, Wang L, Zou X. SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism. Neoplasia 2018;20:745-56. [PMID: 29925042 DOI: 10.1016/j.neo.2018.03.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
13 Ye Q, Zhang M, Wang Y, Fu S, Han S, Wang L, Wang Q. Sirtinol regulates the balance of Th17/Treg to prevent allograft rejection. Cell Biosci 2017;7:55. [PMID: 29090089 DOI: 10.1186/s13578-017-0182-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
14 Jiang X, Kanda T, Haga Y, Sasaki R, Nakamura M, Wu S, Nakamoto S, Shirasawa H, Okamoto H, Yokosuka O. Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication. Exp Ther Med 2017;13:3305-8. [PMID: 28587404 DOI: 10.3892/etm.2017.4407] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang M, Pan Y, Dorfman RG, Yin Y, Zhou Q, Huang S, Liu J, Zhao S. Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2. Sci Rep. 2017;7:7. [PMID: 28127057 DOI: 10.1038/s41598-017-00035-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 118] [Article Influence: 22.6] [Reference Citation Analysis]
16 Dey D, Banerjee M. Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis. J Clin Transl Hepatol 2016;4:248-57. [PMID: 27777893 DOI: 10.14218/JCTH.2016.00025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]